Press releases
- Alvotech and Dr. Reddy’s Enter Into Collaboration for Commercialization of AVT03 (denosumab), a Biosimilar Candidate to Prolia® & Xgeva® in the U.S., Europe and UK
- Dr. Reddy’s Q4 & Full Year FY24 Financial Results
- Dr. Reddy's Laboratories Announces the Launch of Doxycycline Capsules, 40 mg* in the U.S.
- Dr. Reddy's Laboratories launches Versavo® (bevacizumab) in the UK
Key statistics
On Thursday, Dr Reddy's Laboratories Ltd (R1DY34:SAO) closed at 62.64, -10.51% below its 52-week high of 70.00, set on Aug 03, 2023.
52-week range
Open | -- |
---|---|
High | -- |
Low | -- |
Bid | 59.58 |
Offer | 60.30 |
Previous close | 62.64 |
Average volume | -- |
---|---|
Shares outstanding | -- |
Free float | -- |
P/E (TTM) | -- |
Market cap | -- |
EPS (TTM) | -- |
Annual div (ADY) | 0.4119 BRL |
---|---|
Annual div yield (ADY) | 0.54% |
Div ex-date | Jul 07 2023 |
Div pay-date | Aug 17 2023 |
Data delayed at least 15 minutes, as of May 23 2024 20:54 BST.
More ▼